Table 1.

Summary of DCE attributes and attribute levels [6, 36–41]

	Deprescribing alternative	Status quo alternative (medicines continued)
Attributes	Levels	Fixed levels
Potential harms of deprescribing antihypertensive medicines over the next year
1. Risk of stroke	1 out of 100 people 2 out of 100 people 7 out of 100 people	1 out of 100 people
2. Risk of myocardial infarction	1 out of 100 people 2 out of 100 people 9 out of 100 people	1 out of 100 people
3. Risk of significant increase in blood pressure	18 out of 100 people 24 out of 100 people 31 out of 100 people	1 out of 100 people
Potential benefits of deprescribing antihypertensive medicines over the next year
4. Risk of falls	5 out of 100 people 11 out of 100 people 26 out of 100 people	32 out of 100 people
5. Risk of noticeable decline in cognitive function	25 out of 100 people 33 out of 100 people 40 out of 100 people	33 out of 100 people
6. Number tablets taken per day (pill burden)	One less tablet per day Two less tablets per day Three less tablets per day	No change in number of tablets per day